1. Home
  2. CPRX vs MRCY Comparison

CPRX vs MRCY Comparison

Compare CPRX & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • MRCY
  • Stock Information
  • Founded
  • CPRX 2002
  • MRCY 1981
  • Country
  • CPRX United States
  • MRCY United States
  • Employees
  • CPRX N/A
  • MRCY N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • MRCY
  • Sector
  • CPRX Health Care
  • MRCY
  • Exchange
  • CPRX Nasdaq
  • MRCY Nasdaq
  • Market Cap
  • CPRX 2.6B
  • MRCY 2.8B
  • IPO Year
  • CPRX 2006
  • MRCY 1998
  • Fundamental
  • Price
  • CPRX $19.83
  • MRCY $53.41
  • Analyst Decision
  • CPRX Strong Buy
  • MRCY Hold
  • Analyst Count
  • CPRX 6
  • MRCY 7
  • Target Price
  • CPRX $32.83
  • MRCY $50.29
  • AVG Volume (30 Days)
  • CPRX 1.4M
  • MRCY 609.8K
  • Earning Date
  • CPRX 08-06-2025
  • MRCY 08-11-2025
  • Dividend Yield
  • CPRX N/A
  • MRCY N/A
  • EPS Growth
  • CPRX 183.96
  • MRCY N/A
  • EPS
  • CPRX 1.65
  • MRCY N/A
  • Revenue
  • CPRX $558,499,000.00
  • MRCY $887,477,000.00
  • Revenue This Year
  • CPRX $16.37
  • MRCY $7.76
  • Revenue Next Year
  • CPRX $8.80
  • MRCY $6.37
  • P/E Ratio
  • CPRX $11.91
  • MRCY N/A
  • Revenue Growth
  • CPRX 28.55
  • MRCY 5.66
  • 52 Week Low
  • CPRX $16.06
  • MRCY $32.32
  • 52 Week High
  • CPRX $26.58
  • MRCY $55.40
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 37.75
  • MRCY 54.76
  • Support Level
  • CPRX $19.15
  • MRCY $51.86
  • Resistance Level
  • CPRX $22.53
  • MRCY $55.40
  • Average True Range (ATR)
  • CPRX 0.73
  • MRCY 1.51
  • MACD
  • CPRX -0.03
  • MRCY 0.04
  • Stochastic Oscillator
  • CPRX 24.26
  • MRCY 61.86

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: